Mar 24, 2020
EmphyCorp News: As Reported in The Lancet - Clinical Features of Patients Infected with the 2019 novel Coronavirus in Wuhan, China
Mar 17, 2020
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus
Mar 16, 2020
Insmed Provides Business Update
Jan 27, 2020
Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosporine
Nov 26, 2019
Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease
Oct 01, 2019
Global IgG4-Related Disease Market Insights, Epidemiology, and Market Forecast to 2028
Aug 23, 2019
Lilly Announces Top-Line Phase 3 Results for Oral JAK Inhibitor Baricitinib, in Combination with Topical Corticosteroids in Adult Patients with Moderate to Severe Atopic Dermatitis
Jul 08, 2019
4D pharma plc Commences Phase I/II Asthma Trial
Jul 08, 2019
EyePoint Pharmaceuticals, Inc. - U.S. Commercialization of DEXYCU® (dexamethasone intraocular suspension) 9%
Jun 26, 2019
FDA approves first treatment for chronic rhinosinusitis with nasal polyps
May 23, 2019
Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency
May 08, 2019
Public Invited to Attend National Landmark Ceremony at the Kalamazoo Valley Museum
May 07, 2019
Dupixent® (dupilumab) Approved for Severe Asthma by European Commission
Mar 28, 2019
Global COPD Drugs Market is projected to display robust growth represented by a CAGR of 2.47% during 2018 - 2023
Feb 28, 2019
Stero Biotechs to Commence Phase 2 Clinical Trial of ST-AH-01 Cannabidiol Formulation for Ground Breaking Maintenance Therapy and Steroid Reduction in Patients With Autoimmune Hepatitis
Feb 04, 2019
Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis
Nov 15, 2018
Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology
Oct 26, 2018
First Patient Screened in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Sep 27, 2018
AFYX Therapeutics Presents Clinical and Preclinical Research on Rivelin Treatment for Mucosal Diseases at 14th Biennial Congress of European Association of Oral Medicine
Sep 27, 2018
Kalamazoo Valley Museum to Display American Chemical Society's National Historical Landmark Plaque